Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus

Lichen planus is a chronic inflammatory mucocutaneous disease that belongs to the group of papulosquamous skin diseases among diseases like psoriasis, a widely studied disease in dermatology. The aim of the study was to identify the changes between the blood sera of lichen planus patients and health...

Full description

Bibliographic Details
Main Authors: Liis Ilves, Aigar Ottas, Liisi Raam, Mihkel Zilmer, Tanel Traks, Viljar Jaks, Külli Kingo
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/1/91
_version_ 1797438824983298048
author Liis Ilves
Aigar Ottas
Liisi Raam
Mihkel Zilmer
Tanel Traks
Viljar Jaks
Külli Kingo
author_facet Liis Ilves
Aigar Ottas
Liisi Raam
Mihkel Zilmer
Tanel Traks
Viljar Jaks
Külli Kingo
author_sort Liis Ilves
collection DOAJ
description Lichen planus is a chronic inflammatory mucocutaneous disease that belongs to the group of papulosquamous skin diseases among diseases like psoriasis, a widely studied disease in dermatology. The aim of the study was to identify the changes between the blood sera of lichen planus patients and healthy controls to widen the knowledge about the metabolomic aspect of lichen planus and gain a better understanding about the pathophysiology of the disease. We used high-throughput nuclear magnetic resonance (NMR) spectroscopy to measure the levels of blood serum metabolites, lipoproteins and lipoprotein particles. Dyslipidemia has relatively recently been shown to be one of the comorbidities of lichen planus, but the changes in the components of lipoproteins have not been described yet. We found statistically significant changes in the concentrations of 16 markers regarding lipoproteins, which included the components of intermediate-density lipoproteins, low-density lipoproteins and large low-density lipoproteins. We propose that the detected changes may increase the risk for specific comorbidities (e.g., dyslipidemia) and resulting cardiovascular diseases, as the turnover and hepatic uptake of the altered/modified lipoprotein particles are disturbed.
first_indexed 2024-03-09T11:42:54Z
format Article
id doaj.art-d2eb07e6039b42bcbbfd32d6e9aec1e6
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T11:42:54Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-d2eb07e6039b42bcbbfd32d6e9aec1e62023-11-30T23:28:52ZengMDPI AGMetabolites2218-19892023-01-011319110.3390/metabo13010091Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen PlanusLiis Ilves0Aigar Ottas1Liisi Raam2Mihkel Zilmer3Tanel Traks4Viljar Jaks5Külli Kingo6Department of Dermatology and Venereology, University of Tartu, 50417 Tartu, EstoniaDepartment of Biochemistry, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, EstoniaDepartment of Dermatology and Venereology, University of Tartu, 50417 Tartu, EstoniaDepartment of Biochemistry, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, EstoniaDepartment of Dermatology and Venereology, University of Tartu, 50417 Tartu, EstoniaDermatology Clinic, Tartu University Hospital, 50417 Tartu, EstoniaDepartment of Dermatology and Venereology, University of Tartu, 50417 Tartu, EstoniaLichen planus is a chronic inflammatory mucocutaneous disease that belongs to the group of papulosquamous skin diseases among diseases like psoriasis, a widely studied disease in dermatology. The aim of the study was to identify the changes between the blood sera of lichen planus patients and healthy controls to widen the knowledge about the metabolomic aspect of lichen planus and gain a better understanding about the pathophysiology of the disease. We used high-throughput nuclear magnetic resonance (NMR) spectroscopy to measure the levels of blood serum metabolites, lipoproteins and lipoprotein particles. Dyslipidemia has relatively recently been shown to be one of the comorbidities of lichen planus, but the changes in the components of lipoproteins have not been described yet. We found statistically significant changes in the concentrations of 16 markers regarding lipoproteins, which included the components of intermediate-density lipoproteins, low-density lipoproteins and large low-density lipoproteins. We propose that the detected changes may increase the risk for specific comorbidities (e.g., dyslipidemia) and resulting cardiovascular diseases, as the turnover and hepatic uptake of the altered/modified lipoprotein particles are disturbed.https://www.mdpi.com/2218-1989/13/1/91lichen planusdermatologylipids
spellingShingle Liis Ilves
Aigar Ottas
Liisi Raam
Mihkel Zilmer
Tanel Traks
Viljar Jaks
Külli Kingo
Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
Metabolites
lichen planus
dermatology
lipids
title Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
title_full Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
title_fullStr Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
title_full_unstemmed Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
title_short Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
title_sort changes in lipoprotein particles in the blood serum of patients with lichen planus
topic lichen planus
dermatology
lipids
url https://www.mdpi.com/2218-1989/13/1/91
work_keys_str_mv AT liisilves changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT aigarottas changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT liisiraam changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT mihkelzilmer changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT taneltraks changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT viljarjaks changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus
AT kullikingo changesinlipoproteinparticlesinthebloodserumofpatientswithlichenplanus